- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Peloton Q1 Earnings & Revenues Surpass Estimates, Stock Up | ||
| Fr | DBX Q3 Earnings Beat Estimates, Revenues Fall Y/Y, Shares Rise | ||
| Fr | Microchip Q2 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop | ||
| Fr | Block's Q3 Earnings & Revenues Miss Estimates, 2025 Guidance Raised | ||
| Fr | AngloGold Ashanti to Report Q3 Results: What's in the Cards? | ||
| Fr | KKR Q3 Earnings Top Estimates as AUM Rises Y/Y, Stock Gains | ||
| Fr | Main Street Capital Q3 Earnings Miss Estimates, Expenses Rise Y/Y | ||
| Fr | Insperity Stock Declines 23% After Reporting Q3 Earnings Miss | ||
| Fr | Fiserv Q3 Earnings Miss Estimates on Weak Margins, Revenues Fall Y/Y | ||
| Fr | Warner Bros. Discovery Q3 Earnings Miss Estimates, Revenues Fall Y/Y | ||
| Fr | Acadia Q3 Earnings Beat on Growing Volumes, Guidance Lowered | ||
| Fr | LAMR Beats Q3 AFFO Estimates, Reaffirms 2025 Outlook for Steady Growth | ||
| Fr | Should Investors Bet on UPS Post Its Andlauer Healthcare Buyout? | ||
| Fr | TPR Stock Falls 10% Despite Q1 Earnings Beat & Raised FY26 Outlook | ||
| Fr | PGR vs. WRB: Which P&C Insurance Stock is a Smarter Investment? | ||
| Fr | Mission Produce vs. Dole: Who's Winning Global Fresh Produce Battle? | ||
| Fr | Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call | ||
| Fr | Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised | ||
| Fr | ESPR's Q3 Earnings Lag Estimates, Revenues Rise Y/Y, Stock Down | ||
| Fr | Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales | ||
| Fr | Is SoFi Technologies Stock a Buy After Another Record Quarter? | ||
| Fr | Capital One Stock Rises 21.6% YTD: Is There More Upside Ahead? | ||
| Fr | Scotts Miracle-Gro's Q4 Earnings and Revenues Miss Estimates | ||
| Fr | Middleby's Q3 Earnings and Sales Beat Estimates, Increase Y/Y | ||
| Fr | IONQ Stock Jumps Despite Wider Q3 Losses: Hold or Book Profit Now? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .